Roberto Nani
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Liver physiology and pathology
Papers in
-
- Renal cell carcinoma treatment 1
- Radiation Therapy and Dosimetry 1
- Renal and Vascular Pathologies 1
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Co-authors
- Luigi Bolondi (1 shared paper)Roberto Cioni (1 shared paper)Carlo Bartolozzi (1 shared paper)Rita Golfieri (1 shared paper)G Gandini (1 shared paper)Matteo Renzulli (1 shared paper)Irene Bargellini (1 shared paper)Andrea Doriguzzi Breatta (1 shared paper)
- Journals
- World Journal of Clinical Oncology (1 paper)Skeletal Radiology (1 paper)International Journal of Technology Management (1 paper)Liver Transplantation (1 paper)Future Oncology (1 paper)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Roberto Nani
14 papers receiving 673 citations
Roberto Nani's Hit Papers
Peers
Comparison fields: 5 of 65
- Hepatology 506
- Transplantation 12
- Epidemiology 148
- Pathology and Forensic Medicine 72
- Pulmonary and Respiratory Medicine 91
Countries citing papers authored by Roberto Nani
This map shows the geographic impact of Roberto Nani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Nani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Nani more than expected).
Fields of papers citing papers by Roberto Nani
This network shows the impact of papers produced by Roberto Nani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Nani. The network helps show where Roberto Nani may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Nani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma Hit paper breakdown → | 2014 | 449 |
| 2 | 2019 | 38 | |
| 3 | 2010 | 35 | |
| 4 | 2007 | 33 | |
| 5 | 2020 | 30 | |
| 6 | 2001 | 28 | |
| 7 | 2017 | 24 | |
| 8 | 2017 | 14 | |
| 9 | 2023 | 10 | |
| 10 | 2002 | 9 | |
| 11 | 2011 | 6 | |
| 12 | 2008 | 5 | |
| 13 | 2018 | 4 | |
| 14 | 2021 | 3 | |
| 15 | 2025 | 0 | |
| 16 | TRIZ-Based Patent Investigation by Evaluating Inventiveness. | 2008 | 0 |
| 17 | 2018 | 0 | |
| 18 | 2017 | 0 | |
| 19 | 2011 | 0 |
About Roberto Nani
Roberto Nani is a scholar working on Pulmonary and Respiratory Medicine, Hepatology, Oncology, Biomedical Engineering and Management of Technology and Innovation, having authored 19 papers that have together received 688 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Intellectual Property and Patents (2 papers), Ultrasound and Hyperthermia Applications (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Renal cell carcinoma treatment (1 paper), Radiation Therapy and Dosimetry (1 paper) and Renal and Vascular Pathologies (1 paper). The work is most often cited by research in Hepatology (506 citations), Transplantation (12 citations), Epidemiology (148 citations), Pathology and Forensic Medicine (72 citations) and Pulmonary and Respiratory Medicine (91 citations). Roberto Nani has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Luigi Bolondi, Roberto Cioni, Carlo Bartolozzi, Rita Golfieri, G Gandini, Matteo Renzulli, Irene Bargellini, Andrea Doriguzzi Breatta, Daniele Gasparini and Emanuela Giampalma. Their work appears in journals such as World Journal of Clinical Oncology, Skeletal Radiology, International Journal of Technology Management, Liver Transplantation and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.